Back
NVIDIA Vs. Akero Therapeutics Industry Stock Comparison
Sell
42
NVDA
NVIDIA
Last Price:
$124.85
Seasonality Move:
14.93%
Buy
57
AKRO
Akero Therapeutics
Last Price:
$55.30
Seasonality Move:
-13.54%
Sell
42
NVIDIA (NVDA)
is a Sell
Is NVIDIA a Buy, Sell or Hold?
-
NVDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.00. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVDA Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
NVDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.09 | Sell |
Relative Strength Index (14 RSI): | 40.77 | Sell |
Chaikin Money Flow: | 28389123 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (130.5 - 144.14) | Sell |
Bollinger Bands (100): | (122.36 - 144.58) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.24 | Buy |
Relative Strength Index (14 RSI): | 85.85 | Buy |
Chaikin Money Flow: | 423269 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.76 - 38.18) | Buy |
Bollinger Bands (100): | (24.88 - 34.36) | Buy |
NVDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 135.82 | Sell |
20-day SMA: | 137.08 | Sell |
50-day SMA: | 138.17 | Sell |
200-day SMA: | 121.91 | Buy |
8-day EMA: | 132.29 | Sell |
20-day EMA: | 135.54 | Sell |
50-day EMA: | 136.41 | Sell |
200-day EMA: | 119.68 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.66 | Buy |
20-day SMA: | 29.67 | Buy |
50-day SMA: | 29.97 | Buy |
200-day SMA: | 26.38 | Buy |
8-day EMA: | 39.78 | Buy |
20-day EMA: | 32.93 | Buy |
50-day EMA: | 30.49 | Buy |
200-day EMA: | 28.24 | Buy |
NVIDIA Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.11 per share, an increase this year of $1.71 per share, and an increase next year of $1.49 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and an increase next year of $0.08 per share.
NVIDIA Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |